Free Trial
NASDAQ:AIKI

AIkido Pharma (AIKI) Stock Price, News & Analysis

AIkido Pharma logo
$2.03 -0.10 (-4.69%)
As of 10/13/2026

About AIkido Pharma Stock (NASDAQ:AIKI)

Advanced

Key Stats

Today's Range
$2.02
▼
$2.11
50-Day Range
$1.94
▼
$3.14
52-Week Range
$3.31
▼
$11.48
Volume
78,797 shs
Average Volume
79,326 shs
Market Capitalization
$11.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

AIkido Pharma Inc. was a development-stage biotechnology company focused on identifying, acquiring and developing therapeutic candidates for cancer and other serious diseases. Its activities centered on advancing early-stage pharmaceutical programs rather than marketing an established portfolio of commercial products.

The company pursued drug-development opportunities through research collaborations, intellectual-property licensing and strategic acquisitions. Its programs included investigational treatments aimed at oncology applications, including pancreatic cancer, as well as other therapeutic areas explored through external technologies and partnerships.

AIkido Pharma’s operations were primarily research and development-oriented, and publicly available information provides limited detail about a broad commercial presence, geographic operations or a current leadership team. The company’s business profile and program priorities may have changed over time as it evaluated potential licensing and development opportunities.

AI Generated. May Contain Errors.

Receive AIKI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AIkido Pharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AIKI Stock News Headlines

AIkido Pharma Inc. Common Stock (AIKI)
Rent out your stocks?
If you owned a rental house, you would collect rent while you waited for it to rise in value. A covered call lets you do something similar with stocks you already own. Own at least 100 shares and you can get paid cash today for agreeing to sell them at a higher price later. That cash is yours to keep no matter what happens next. Bill Poulos breaks it down in The Retirement Paycheck Playbook, normally $29.97, free today.tc pixel
See More Headlines

AIKI Stock Analysis - Frequently Asked Questions

AIkido Pharma's stock was trading at $4.95 on January 1st, 2026. Since then, AIKI shares have decreased by 57.0% and is now trading at $2.13.

AIkido Pharma's stock reverse split on the morning of Tuesday, June 7th 2022.The 1-17 reverse split was announced on Tuesday, June 7th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

AIkido Pharma subsidiaries include Hoth Therapeutics.

Shares of AIKI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AIkido Pharma investors own include Bionano Genomics (BNGO), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Jaguar Animal Health (JAGX), Ocugen (OCGN), Palantir Technologies (PLTR) and Castor Maritime (CTRM).

Company Calendar

Today
10/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Capital Markets
Sub-Industry
Investment Banking & Brokerage
Current Symbol
NASDAQ:AIKI
CIK
12239
Employees
4
Year Founded
1967

Profitability

EPS (Trailing Twelve Months)
($3.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.17 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-18.21%
Return on Assets
-16.94%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
29.54
Quick Ratio
29.54

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$19.27 per share
Price / Book
0.11

Miscellaneous

Outstanding Shares
5,485,000
Free Float
5,013,000
Market Cap
$11.68 million
Optionable
Not Optionable
Beta
0.93

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:AIKI) was last updated on 10/13/2026 by MarketBeat.com Staff.
From Our Partners